Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy

Front Pharmacol. 2024 Jan 17:15:1343756. doi: 10.3389/fphar.2024.1343756. eCollection 2024.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1150270.].

Keywords: MG-63; VEGFR2; benzylisoquinoline alkaloids; osteosarcoma; stylopine.

Publication types

  • Published Erratum